Regulatory Oversight, Coronavirus/COVID-19, Acquisitions

Changes to foreign investment control in Poland signal a shift in approach

A&O Shearman on 8/4/2025

On July 24, 2025, amendments to Poland’s investment control regime entered into force. Notably, the temporary foreign direct investment (FDI) provisions introduced in response to the COVID-19 pandemic in 2020 have now become...more

Policy shifts may signal a new chapter in the story of globalization

White & Case LLP on 4/1/2022

Globalization may be evolving, as nations and regions reassert their regulatory powers on a wide range of issues including trade, competition and national security. The economic lessons of COVID-19 and growing concerns about...more

IFLR M&A Report - 2022

Latham & Watkins LLP on 3/30/2022

The recovery of the M&A market since the early days of the pandemic has been impressive. Even allowing for varying treatment of Covid-19 winners and losers, deal processes for resilient assets (and even for less obviously...more

What's in store for 2022?

White & Case LLP on 2/7/2022

Five factors that will shape dealmaking over the coming 12 months - Last year will be a very tough act to follow. M&A values and volumes soared on the back of confident public markets, strong deal financing options and a...more

Mergers and Acquisitions in the Transportation Sector

Benesch on 8/24/2020

One effect of the COVID-19 pandemic is the renewed need for transportation providers to consider strengthening operating platforms by expanding into new markets, integrating new offerings or adjacent services, or growing the...more

[Webinar] Diagnostics, Antibody Testing and Vaccines: Global Outlook on Life Sciences COVID-19 Advances and Evolving Deal Trends -...

McDermott Will & Schulte on 5/5/2020

Across the US and EU, life sciences companies are pushing diagnostics, antibody testing, vaccines and other efforts forward to flatten the Coronavirus (COVID-19) curve. Our multidisciplinary cross-border life sciences team...more